Clorox Healthcare Rolls Out Optimum-UV Enlight System

Clorox Healthcare, in partnership with Ultraviolet Devices, Inc. (UVDI), is rolling out the Clorox Healthcare Optimum-UV Enlight System, which kills a total of 31 pathogens and combines powerful UV technology with advanced data collection and reporting capabilities, clinically proven efficacy and affordability to enable facility-wide adoption.

Clorox is introducing the system at the Association for the Healthcare Environment (AHE) Exhange 2015 annual conference. 
 
According to Clorox, the Optimum-UV Enlight System is designed to supplement manual disinfection efforts with U.S. Environmental Protection Agency (EPA) registered disinfectants. Combining manual surface disinfection with UV technology ensures thorough coverage, especially on areas that may be missed during manual cleaning. However, a comprehensive approach also hinges upon having a well-trained and educated environmental services staff to implement best practices.
 
“We know that environmental services and infection control professionals are looking for more efficient and easy-to-use ways to implement UV devices and track infection rates across their facilities, which can be a time-intensive process,” said Dr. Katherine Velez, scientist, Clorox Healthcare. “The Optimum-UV Enlight System's smart data capabilities help do the heavy lifting to improve infection control processes and minimize workflow challenges so that UV can be seamlessly integrated into larger environmental infection control practices.”
 
The Optimum-UV Enlight System kills 31 pathogens in five minutes at a distance of eight feet and also keeps accurate reports of infection rates and outbreaks to enhance patient safety efforts.
 
Increasingly, healthcare facilities are required to accurately report their infection rates to receive Medicare and Medicaid reimbursements.
 
Specifically, the Optimum-UV Enlight System kills 31 total pathogens in five minutes at a distance of eight feet, including a 4-log reduction of Clostridium difficile (C. difficile) spores and a greater than 5-log reduction of more than 20 pathogens such as methicillin- resistant Staphylococcus aureus (MRSA), vancomycin-resistant Enterococci (VRE) and carbapenem-resistant Enterobacteriaceae (CRE).(2)
 
The system tracks device usage across rooms, locations, and operators, and provides automated reporting that is accessible in real time. The system also provides diagnostic data with automated alerts to inform users about maintenance needs and helps to identify areas for targeted staff training.